Showing results (431-440 of 476) with videos related to
Sort By:
Pageof 48
Journal of Pediatric Hematology/Oncology|August 1, 1995
Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood: a Pediatric Oncology Group Phase I/II studyF H Kung, S J Desai, J D Dickerman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institutionM E Horowitz, C B Pratt, B L Webber, et al.The New England Journal of Medicine|June 19, 1986
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremityM P Link, A M Goorin, A W Miser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Treatment of intraocular retinoblastoma with vincristine and carboplatinCarlos Rodriguez-Galindo, Matthew W Wilson, Barrett G Haik, et al.Medical and Pediatric Oncology|February 25, 1998
A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomasA W Walter, P D Shearer, A S Pappo, et al.The Journal of Biological Chemistry|January 5, 1988
A region in the steroid binding domain determines formation of the non-DNA-binding, 9 S glucocorticoid receptor complexW B Pratt, D J Jolly, D V Pratt, et al.Seminars in Oncology|February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988C B Pratt, E C Douglass, E Etcubanas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1991
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapyW L Furman, D L Fairclough, R D Huhn, et al.Transplantation|October 9, 1999
Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal functionB Cuhaci, M S Kumar, R D Bloom, et al.Journal of Pediatric Hematology/Oncology|November 1, 1996
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group studyD G Tubergen, C F Stewart, C B Pratt, et al.Pageof 48